Is RPG LifeScience. overvalued or undervalued?
As of October 31, 2025, RPG LifeScience is fairly valued with a PE ratio of 35.76, a PEG ratio of 0.84, strong ROCE of 46.94%, and has outperformed the Sensex with a 188.28% return over three years, compared to its peers like Sun Pharma and Cipla.
As of 31 October 2025, RPG LifeScience has moved from an expensive to a fair valuation grade. The company is currently fairly valued, with a PE ratio of 35.76, a Price to Book Value of 7.51, and an EV to EBITDA of 24.94. In comparison to its peers, Sun Pharma has a PE ratio of 35.35 and an EV to EBITDA of 23.98, while Cipla stands out with a more attractive PE ratio of 22.29 and an EV to EBITDA of 5.55.RPG LifeScience's PEG ratio of 0.84 indicates potential for growth relative to its price, and the company boasts a strong ROCE of 46.94% and ROE of 21.01%. Notably, the stock has outperformed the Sensex over the past three years, returning 188.28% compared to the Sensex's 38.18%, reinforcing its fair valuation amidst a competitive landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
